Evidence map›Paper›PMID 41917523›Full record

ArticleCommunications biology2026

Amyloid fibril polymorphism in the heart and liver of a patient with polyneuropathic ATTRv-V122Δ amyloidosis.

Yasmin Ahmed, Binh An Nguyen, Candace Kelly, Shumaila Afrin, Virender Singh, Bret M Evers, John M Shelton, Christian Lopez Escobar, Preeti Singh, Rose Pedretti and 7 more

Abstract readCase Reports
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Transthyretin amyloid fibrils adopt distinct folds in the brain.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yasmin Ahmed *Department of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Binh An Nguyen *Department of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0001-7055-8809
Candace KellyDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Shumaila AfrinDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Virender SinghDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0002-6720-8784
Bret M EversDepartment of Pathology, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0001-5686-0315
John M SheltonDepartment of Pathology, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0002-2949-1638
Christian Lopez EscobarDepartment of Pathology, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0009-0005-1820-0144
Preeti SinghDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0003-2508-5613
Rose PedrettiDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Lanie WangDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Parker BassettDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0009-0001-5162-7212
Maria Del Carmen Fernandez-RamirezDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0002-3265-5242
Maja PekalaDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Andrew LemoffDepartment of Biochemistry, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0002-4943-0170
Barbara Kluve-BeckermanDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Lorena SaelicesDepartment of Biophysics, Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA. lorena.saelicesgomez@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-1904-2150

Funding

American Heart Association (American Heart Association, Inc.) 847236Welch Foundation I-2121-20220331
6 · The paper itself

Abstract

ATTR amyloidosis is a phenotypically heterogeneous disease characterized by the pathological deposition of transthyretin in the form of amyloid fibrils into various organs. ATTR amyloidosis may result from mutations in variant (ATTRv) amyloidosis, or aging in wild-type (ATTRwt) amyloidosis. ATTRwt generally manifests as cardiomyopathy, whereas ATTRv may present as polyneuropathy, cardiomyopathy, or mixed, in combination with many other symptoms deriving from multisystem organ involvement. Over 220 different mutational variants of transthyretin have been identified, many of them being linked to specific disease symptoms. Yet, the role of these mutations in explaining differential disease manifestations remains unclear. Using cryo-electron microscopy, here we structurally characterized fibrils from the heart and the liver of an ATTRv patient carrying the V122∆ mutation, which is predominantly associated with polyneuropathy. Our results show that these fibrils are polymorphic, presenting as both single and double filaments. Our study alludes to a structural connection contributing to phenotypic variation in ATTR amyloidosis, as polymorphism in ATTR fibrils may manifest in patients with predominantly polyneuropathic phenotypes.

Indexed as

AmyloidAmyloid Neuropathies, FamilialAmyloidosisLiverMyocardiumPolymorphism, GeneticPolyneuropathiesPrealbuminCryoelectron MicroscopyFemaleHumansMaleMutationAmyloidPrealbumin

Identifiers

PMID41917523
PMCPMC13201594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.